To Study the Effects of Simvastatin on Lipid Profile in Obese Patients
Keywords:
Simvastatin, Lipid Profile, Obesity.Abstract
Simvastatin is a competitive inhibitor of HMG-CoA (3Hydroxy 3Methyl Glutaryl Coenzyme A) reductase. 20 male and 20 female obese patients were selected. The obese patients were re-examined three times i.e. before giving the simvastatin, then after 6 and 12 weeks. The patients were advised to take fat free diet and a morning walk. Serum Cholesterol, serum Triglycerides and serum Lipoprotiens (HDL, LDL) was carried out by Standard kit methods (Merck). This study shows that with use of Simvastatin serum cholesterol, serum triglycerides, and serum LDL-Cholesterol was reduced significantly and serum HDL-Cholesterol increased significantly in both sexes and causes weight reduction which may be due to low calorie diet and physical exercise. It is therefore concluded that Simvastatin shows significant lipid lowering effects and also reduced the body weight, if patients used calorie restricted diet with some morning walk.
Downloads
Published
How to Cite
Issue
Section
License
The Journal of Fatima Jinnah Medical University follows the Attribution Creative Commons-Non commercial (CC BY-NC) license which allows the users to copy and redistribute the material in any medium or format, remix, transform and build upon the material. The users must give credit to the source and indicate, provide a link to the license, and indicate if changes were made. However, the CC By-NC license restricts the use of material for commercial purposes. For further details about the license please check the Creative Commons website. The editorial board of JFJMU strives hard for the authenticity and accuracy of the material published in the journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board.
